[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335628-105":59,"doc-detail-335628-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","exploring-osteosarcoma-based-on-the-tumor-microenvironment-research-article","Exploring osteosarcoma based on the tumor microenvironment - Research article","","Osteosarcoma is a malignant bone tumor marked by early metastasis, drug resistance, high disability, and mortality. Immune features within the tumor microenvironment (TME) are important for prognosis and treatment, yet sensitive prognostic signatures are still needed. Using 84 osteosarcoma samples from UCSC Xena, immune infiltration was assessed and patients were grouped by immune properties. Differentially expressed genes were identified, immune-related IR-DEGs were derived using TIMER, and univariate COX and LASSO models built an immune prognostic risk signature with survival and immune checkpoint analyses.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-osteosarcoma-based-on-the-tumor-microenvironment-research-article/335628/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-osteosarcoma-based-on-the-tumor-microenvironment-research-article/335628.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"What did the risk scoring show about patient prognosis and immune checkpoint relevance?","Question",{"text":112,"@type":113},"Survival analysis showed notable prognostic differences between high-risk and low-risk groups, and the model’s conclusions were consistent with prior reports while also producing meaningful results in immune checkpoint analyses.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},335628,1790501656,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":137,"preview_page_count":4},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","TYPE Original Research PUBLISHED 25 November 2024 DOI 10.3389/fimmu.2024.1423194  \nOPEN ACCESS  \nEDITED BY  \nSusan (krum) Miranda,  \nUniversity of Tennessee Health Science Center (UTHSC), United States  \nREVIEWED BY  \nMeng Jia,  \nUniversity of Pennsylvania, United States Jeong A Park,  \nInha University Hospital, Republic of Korea  \n*CORRESPONDENCE  \nSi-shan Bian  \n [sdszyybss@163.com](sdszyybss@163.com)  \nRECEIVED 25 April 2024  \nACCEPTED 07 November 2024  \nPUBLISHED 25 November 2024  \nCITATION  \nWu A, Yang Z-k, Kong P, Yu P, Li Y-t, Xu J-l, Bian S-s and Teng J-w (2024) Exploring  \nosteosarcoma based on the tumor microenvironment.  \nFront. Immunol. 15:1423194 .  \ndoi: 10.3389/fimmu.2024.1423194  \nCOPYRIGHT  \n© 2024 Wu, Yang, Kong, Yu, Li, Xu, Bian and Teng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nExploring osteosarcoma based on the tumor microenvironment  \nAo Wu 1, Zhi-kai Yang 2, Peng Kong 3, Peng Yu1, You-tong Li 1, Jia-le Xu 1, Si-shan Bian 4* and Jia-wen Teng 4  \n1The First Clinical College of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China, 2 Hand and Foot Orthopaedic Department, Changle County People ’s Hospital, Weifang, Shandong, China, 3 Department of Minimally Invasive Orthopedics, Afﬁliated Hospital of Shandong Traditional Chinese Medicine University, Jinan, Shandong, China, 4 Department of Traumatology and Orthopaedics, Afﬁliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China  \nOsteosarcoma is a cancerous bone tumor that develops from mesenchymal cells and is characterized by early metastasis, easy drug resistance, high disability, and mortality. Immunological characteristics of the tumor microenvironment (TME) have attracted attention for the prognosis and treatment of osteosarcoma, and there is a need to explore a signature with high sensitivity for prognosis. In the present study, a total of 84 samples of osteosarcoma were acquired from the UCSC Xena database, analyzed for immune inﬁltration and classiﬁed into two categories depending on their immune properties, and then screened for DEGs between the two groups and analyzed for enrichment, with the majority of DEGs enriched in the immune domain. To further analyze their immune characteristics, the immune-related genes were obtained from the TIMER database. We performed an intersection analysis to identify immune-related differentially expressed genes (IR-DEGs), which were analyzed using a univariate COX regression, and LASSO analysis was used to obtain the ideal genes to construct the risk model, and to uncover the prognostic distinctions between high-risk scoring group and low-risk scoring group, a survival analysis was conducted. The risk assessment model developed in this study revealed a notable variation in survival analysis outcomes between the high-risk and low-risk scoring groups, and the conclusions reached by the model are consistent with the ﬁndings of previous scholars. They also yield meaningful results when analyzing immune checkpoints. The risk assessment model developed in this study is precise and dependable for forecasting outcomes and analyzing characteristics of osteosarcoma.  \nKEYWORDS  \nosteosarcoma, tumor microenvironment, immune-related genes, immunotherapy, immunization checkpoints  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nOsteosarcoma(OS) originates from bone tissue and is a malignant tumor with local invasion and rapid inﬁltrative metastasis, prevalent in children and adolescents (1 , 2) . Osteosarcoma has a high disability","cbCailIGuTTD05vB","https://ap.wps.com/l/cbCailIGuTTD05vB","pdf",18456623,15,"English","# Introduction\n## Tumor microenvironment and immune checkpoints\n# Materials and Methods\n## Data sources and immune infiltration grouping\n## Differential expression and enrichment analyses\n# Results\n## IR-DEGs and prognostic risk model\n## Survival differences and immune checkpoint findings\n# Discussion","[{\"question\":\"What did the risk scoring show about patient prognosis and immune checkpoint relevance?\",\"answer\":\"Survival analysis showed notable prognostic differences between high-risk and low-risk groups, and the model’s conclusions were consistent with prior reports while also producing meaningful results in immune checkpoint analyses.\"}]","Exploring osteosarcoma based on the tumor microenvironment - Research article | PDF",1790011710,38]